Literature DB >> 3595765

Mechanisms of compensation of hemolytic anemia in a lactate dehydrogenase mouse mutant.

J P Kremer, T Datta, W Pretsch, D J Charles, P Dörmer.   

Abstract

Hemopoiesis was studied in homozygous lactate dehydrogenase (LDH) mutant mice not showing noticeable impairment in viability and fertility but afflicted with a severe hemolytic anemia. In order to investigate the mechanisms of erythropoietic compensation, the numbers of multipotent hemopoietic stem cells (CFU-S), myeloid (GM-CFC), and early and late erythroid progenitors (BFU-E and CFU-E) in femur and spleen were determined, and the total body content of each cell type was computed. While the total CFU-S and GM-CFC numbers showed only slight deviations from normal, the total BFU-E pool was 1.4 and the CFU-E pool 18 times enlarged. No difference in cell cycle status could be detected in these compartments by means of tritiated thymidine (3H-TdR) suicide in vitro. However, splenic erythroblasts of homozygous LDH mutants had a shorter DNA synthesis time and a higher labeling index compared to the wild type mice. It is concluded that the hemolysis is compensated at a lower level of red blood cell count primarily by an increase in the total number of late erythroid progenitors resulting from roughly four extra divisions, and secondarily by an increase in the flux through the recognizable erythroblast compartments, predominantly a space-saving mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595765

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  7 in total

1.  Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.

Authors:  Haitao Li; Xi Jiang; John Delaney; Tiziana Franceschetti; Ines Bilic-Curcic; Judy Kalinovsky; Joseph A Lorenzo; Danka Grcevic; David W Rowe; Ivo Kalajzic
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

2.  Molecular, genetic and biochemical characterization of lactate dehydrogenase-A enzyme activity mutations in Mus musculus.

Authors:  W Pretsch; B Chatterjee; J Favor; S Merkle; R Sandulache
Journal:  Mamm Genome       Date:  1998-02       Impact factor: 2.957

3.  Genetic, biochemical, and molecular characterization of nine glyceraldehyde-3-phosphate dehydrogenase mutants with reduced enzyme activity in Mus musculus.

Authors:  Walter Pretsch; Jack Favor
Journal:  Mamm Genome       Date:  2007-09-17       Impact factor: 2.957

4.  Characterization of two electrophoretic lactate dehydrogenase-A mutants in Mus musculus.

Authors:  S Merkle; W Pretsch
Journal:  Biochem Genet       Date:  1992-02       Impact factor: 1.890

5.  A mutation affecting the lactate dehydrogenase locus Ldh-1 in the mouse. II. Mechanism of the LDH-A deficiency associated with hemolytic anemia.

Authors:  W Pretsch; S Merkle; J Favor; T Werner
Journal:  Genetics       Date:  1993-09       Impact factor: 4.562

Review 6.  Targeting cancer metabolism in the era of precision oncology.

Authors:  Zachary E Stine; Zachary T Schug; Joseph M Salvino; Chi V Dang
Journal:  Nat Rev Drug Discov       Date:  2021-12-03       Impact factor: 84.694

7.  Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy.

Authors:  Nobu Oshima; Ryo Ishida; Shun Kishimoto; Kristin Beebe; Jeffrey R Brender; Kazutoshi Yamamoto; Daniel Urban; Ganesha Rai; Michelle S Johnson; Gloria Benavides; Giuseppe L Squadrito; Dan Crooks; Joseph Jackson; Abhinav Joshi; Bryan T Mott; Jonathan H Shrimp; Michael A Moses; Min-Jung Lee; Akira Yuno; Tobie D Lee; Xin Hu; Tamara Anderson; Donna Kusewitt; Helen H Hathaway; Ajit Jadhav; Didier Picard; Jane B Trepel; James B Mitchell; Gordon M Stott; William Moore; Anton Simeonov; Larry A Sklar; Jeffrey P Norenberg; W Marston Linehan; David J Maloney; Chi V Dang; Alex G Waterson; Matthew Hall; Victor M Darley-Usmar; Murali C Krishna; Leonard M Neckers
Journal:  Cell Rep       Date:  2020-02-11       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.